ICD-10-CM Billable Code

A18.50

Tuberculosis of eye, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

Tuberculosis of the eye, classified under ICD-10 code A18.50, is a rare form of the bacterial infection tuberculosis that affects eye tissues. This condition occurs when Mycobacterium tuberculosis, the bacteria responsible for tuberculosis, infects eye structures, leading to inflammation and tissue damage. Although tuberculosis most commonly impacts the lungs, it can also involve other parts of the body, including the eyes, potentially causing vision problems if not diagnosed and managed properly.

Causes & Symptoms

Clinical Causes: Spread of Mycobacterium tuberculosis from a primary or latent lung infection through the bloodstream (hematogenous spread) Reactivation of dormant bacteria in eye tissues Direct extension from nearby infected tissues Less commonly, it may result from inadequate treatment of systemic tuberculosis

Key Symptoms: Eye redness and swelling Blurred or decreased vision Eye pain or discomfort Sensitivity to light (photophobia) Floaters or visual disturbances Possible eyelid swelling or painless eye mass in some cases

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. Healthcare providers may perform a thorough eye examination to observe inflammation or other changes. Additional investigations include ocular imaging techniques like slit-lamp microscopy, and laboratory tests such as tuberculin skin test (Mantoux test), interferon-gamma release assays, ocular fluid analysis, and chest X-rays to identify systemic tuberculosis. In some cases, tissue biopsy may be necessary to confirm the diagnosis.

Treatment Protocols: Treatment typically involves a prolonged course of anti-tuberculous medications, which may include isoniazid, rifampicin, ethambutol, and pyrazinamide. The duration of therapy can last several months to ensure complete eradication of the infection. In certain cases, corticosteroids might be prescribed to control inflammation. Regular follow-up with healthcare providers is essential to monitor response to therapy and prevent complications. Surgical intervention is rarely needed but may be considered in cases with structural damage or abscess formation.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is A18.50 a billable ICD-10 code?
Yes, A18.50 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report A18.50?
Clinical documentation must specify the nature of Tuberculosis of eye, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference